Global Chinese Medicinal Materials Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Chinese Medicinal Materials Market Research Report 2024
According to Mr Accuracy reports’s new survey, global Chinese Medicinal Materials market is projected to reach US$ 1919.6 million in 2029, increasing from US$ 874 million in 2022, with the CAGR of 11.8% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Chinese Medicinal Materials market research.
In 2024, the global pharmaceutical market will be about US$1.47 trillion, and the CAGR is expected to be about 5% in the next six years. The pharmaceutical market includes chemical drugs and biological drugs. Biologics will reach $381 billion in 2022. In contrast, the chemicals market is projected to increase from USD 1,005.6 billion in 2018 to USD 1,094 billion in 2022.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Chinese Medicinal Materials market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Yiling Pharmaceutical
China Traditional Chinese Medicine Holdings Co., Ltd.
Huisong Pharmaceuticals
Korea Ginseng Corporation
Daedong Korea Ginseng Co., Ltd.
Guangzhou Pharmaceutical
Yunnan Baiyao
TASLY
Kangmei Pharmaceutical Co. Ltd
Beijing Tong Ren Tang Co. Ltd
Henan Taloph Pharmaceutical Stock Co., Ltd
Guangdong Taiantang Pharmaceutical
BaiYunShan
Kanion Pharmaceutical
Jiangzhong Pharmaceutical
Buchang Pharma
Segment by Type
Plant-based Raw Materials
Animal Raw Materials
Mineral Raw Materials
Food Addition
Pharmaceutical
Health Products
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Chinese Medicinal Materials report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
In 2024, the global pharmaceutical market will be about US$1.47 trillion, and the CAGR is expected to be about 5% in the next six years. The pharmaceutical market includes chemical drugs and biological drugs. Biologics will reach $381 billion in 2022. In contrast, the chemicals market is projected to increase from USD 1,005.6 billion in 2018 to USD 1,094 billion in 2022.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Chinese Medicinal Materials market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company
Yiling Pharmaceutical
China Traditional Chinese Medicine Holdings Co., Ltd.
Huisong Pharmaceuticals
Korea Ginseng Corporation
Daedong Korea Ginseng Co., Ltd.
Guangzhou Pharmaceutical
Yunnan Baiyao
TASLY
Kangmei Pharmaceutical Co. Ltd
Beijing Tong Ren Tang Co. Ltd
Henan Taloph Pharmaceutical Stock Co., Ltd
Guangdong Taiantang Pharmaceutical
BaiYunShan
Kanion Pharmaceutical
Jiangzhong Pharmaceutical
Buchang Pharma
Segment by Type
Plant-based Raw Materials
Animal Raw Materials
Mineral Raw Materials
Segment by Application
Food Addition
Pharmaceutical
Health Products
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Chinese Medicinal Materials report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
